共 63 条
[1]
Bracken M.B., Shepard M.J., Collins W.F., Et al., A randomized, controlled trial of methylprednisoloneor naloxone in the treatment of acute spinal-cord injury, N Engl J Med, 322, pp. 1405-1411, (1990)
[2]
Senter H.J., Venes J.L., Altered blood flow and secondary injury in experimental spinal cord trauma, J Neurosurg, 49, pp. 569-578, (1978)
[3]
Means E.D., Erson D.K., Waters T.R., Kalaf L., Effects of methylprednisolone in compressiontrauma to the feline spinal cord, J Neurosurg, 55, pp. 200-208, (1981)
[4]
Young W., Flamm E.S., Effect of high-dose codicosteroid therapy on blood flow, evoked potentials, and extracellular calcium in experimental spinal injury, J Neurosurg, 57, pp. 667-673, (1982)
[5]
Anderson D.K., Means E.D., Waters T.R., Green E.S., Microvascular perfusion and metabolism ininjured spinal cord after methylprednisolone treatment, J Neurosurg, 56, pp. 106-113, (1982)
[6]
Braughler J.M., Hall E.D., Correlation of methylprednisolone levels in cat spinal cord with its effectson (Na2+ k+)-ATPase, lipid peroxidation, and alpha motor neuron function, J Neurosurg, 56, pp. 838-844, (1982)
[7]
Hall E.D., Braughler J.M., Glucocorticoid mechanisms in acute spinal cord injury: A review andtherapeutic rationale, Surg Neurol, 18, pp. 320-327, (1982)
[8]
Hall E.D., WolfDL, Braughler JM. Effects of a single large dose of methylprednisolone sodiumsuccinate on posttraumatic spinal cord ischemia: Dose-response and time-action analysis, J Neurosurg, 61, pp. 124-130, (1984)
[9]
Braughler J.M., Hall E.D., Means E.D., Waters T.R., Erson D.K., Evaluation of an intensivemethylprednisolone sodium succinate dosing regimen in experimental spinal cord injury, J Neurosurg, 67, pp. 102-105, (1987)
[10]
Molinari G.F., Why model strokes?, Stroke, 19, pp. 1195-1197, (1988)